Dresner Partners Advised Reproductive Science Center of New Jersey on Its Sale to Inception Fertility
June 05, 2024 09:00 ET
|
Dresner Partners
Dresner Partners advised Reproductive Science Center of New Jersey on its sale to Inception Fertility
Scar Healing Institute: 2024 Leading Pioneers of Scar Treatment Announce Phase-Out System for Acne Scar Treatment
June 05, 2024 09:00 ET
|
Scar Healing Institute
Beverly Hills, CA, June 05, 2024 (GLOBE NEWSWIRE) -- Scar Healing Institute, 2024, a leading pioneer of scar treatment, is happy to announce its proprietary Phase-Out System that is innovatively...
Dr. Harry E. Sarles Jr. Honored with Distinguished Alumni Award by UTMB
June 05, 2024 08:43 ET
|
GI Alliance
Dallas, TX, June 05, 2024 (GLOBE NEWSWIRE) -- The University of Texas Medical Branch (UTMB) is proud to announce that Dr. Harry E. Sarles, Jr., MD, MACG, AGAF, has been named a recipient of the...
Assembly Biosciences Presents New Data Highlighting Hepatitis D Virus Entry Inhibitor ABI-6250 at the EASL Congress™ 2024
June 05, 2024 08:00 ET
|
Assembly Biosciences, Inc.
-- Poster highlights promising preclinical profile of ABI-6250 ahead of entry into the clinic, expected by end of 2024 -- SOUTH SAN FRANCISCO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Assembly...
Lifeist Sells Australian Vapes
June 05, 2024 07:00 ET
|
Lifeist Wellness Inc.
Lifeist Sells Australian Vapes a Non-Core Subsidiary to Sharpen its Strategic Focus on Nutraceuticals
and B2B Recreational Cannabis
Inhale-3 Study Results to be Presented During a 90-Minute Symposium on Saturday, June 22 at the American Diabetes Association’s 84th Scientific Sessions
June 05, 2024 06:45 ET
|
MannKind
INHALE-3 STUDY RESULTS TO BE PRESENTED DURING A 90-MINUTE SYMPOSIUM ON SATURDAY, JUNE 22 AT THE AMERICAN DIABETES ASSOCIATION’S 84TH SCIENTIFIC SESSIONS
OSE Immuno et le Centre Hospitalier Universitaire de Nantes présentent une analyse positive de l’essai clinique de Phase 1/2 évaluant l’immunothérapie FR104/VEL-101 en transplantation rénale
June 05, 2024 01:30 ET
|
OSE Immunotherapeutics
OSE Immunotherapeutics et le Centre Hospitalier Universitaire de Nantes présentent une analyse positive de l’essai clinique de Phase 1/2 évaluant l’immunothérapie FR104/VEL-101 en transplantation...
OSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating FR104/VEL-101 Immunotherapy in Renal Transplant
June 05, 2024 01:30 ET
|
OSE Immunotherapeutics
OSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating FR104/VEL-101 Immunotherapy in Renal Transplant At the American Transplant Congress 2024 (June 1-5...
U.S. Coins & Jewelry’s Kenny Duncan Sr. named "Numismatist of the Century"
June 04, 2024 10:50 ET
|
U.S. Coins and Jewelry
Houston, TX, June 04, 2024 (GLOBE NEWSWIRE) -- Family-owned and operated U.S. Coins & Jewelry, Houston’s leader for rare coins, gold and silver bullion, fine jewelry and sought-after sports...
Fathers Incorporated Launches PoppaUniversity.com Ahead of Father's Day
June 04, 2024 10:30 ET
|
Fathers Incorporated
ATLANTA, June 04, 2024 (GLOBE NEWSWIRE) -- For Father's Day, forget the tie, lawn equipment or new tool for the toolbox, give Dad the gift of free advice, endless dad jokes, resources and a virtual...